Hologic Prices $950M Offering of Senior Notes

Sep 15, 2020 | staff reporter

NEW YORK ─ Hologic on Monday said it has priced its previously announced $950 million private offering of 3.250 percent senior notes due in 2029 at an issue price of $1,000 per $1,000.

Marlborough, Massachusetts-based Hologic intends to use the proceeds of the offering and available cash to refinance its existing 4.375 percent senior unsecured notes due 2025 and will use current cash to pay transaction-related premiums, fees, and expenses.

The 2029 notes will be unsecured obligations of the company and guaranteed by certain Hologic subsidiaries. The offering is expected to close on Sept. 28.

Filed under

Infectious Disease

Molecular Diagnostics

senior notes offering

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.